Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters

To generate an inexpensive readily manufactured COVID-19 vaccine, we employed the LVS ΔcapB vector platform, previously used to generate potent candidate vaccines against Select Agent diseases tularemia, anthrax, plague, and melioidosis. Vaccines expressing SARS-CoV-2 structural proteins are constru...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Qingmei, Bielefeldt-Ohmann, Helle, Maison, Rachel M., Masleša-Galić, Saša, Cooper, Sarah K., Bowen, Richard A., Horwitz, Marcus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009914/
https://www.ncbi.nlm.nih.gov/pubmed/33785745
http://dx.doi.org/10.1038/s41541-021-00321-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009914/
https://www.ncbi.nlm.nih.gov/pubmed/33785745
http://dx.doi.org/10.1038/s41541-021-00321-8

Ejemplares similares